Новые правила оплаты регистрации лекарственных средств и медицинских изделий в Узбекистане
December 03, 2024
February 19, 2024
Dr. Polina Dombure, Inpharmatis CEO, Participated in TOPRA Summit 2024
Dr. Polina Dombure, MD, CEO of Inpharmatis Group and a member of the TOPRA, engaged in the TOPRA Summit held on February 15, 2024, in London.
Dr. Dombure exchanged opinions with industry leaders and discussed key success factors essential for shaping the future of a safe regulatory system.
During the TOPRA Summit, dr. Dombure had the opportunity to meet with current and potential partners to discuss the industry’s challenges, as well as collaboration opportunities.
As a leading international consulting company in regulatory affairs, Inpharmatis Group continues to expand collaborations and strengthen its position in the pharmaceutical market.
For more information about Inpharmatis Group and its provided services, please contact us at info@inpharmatis.com.
New Payment Rules for Medicines and Medical Device Registration in Uzbekistan
December 03, 2024
Inpharmatis открыла юридическое лицо в Узбекистане
November 28, 2024
Inpharmatis Opens an LLC Legal Entity in Uzbekistan
November 28, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
October 16, 2024
Dr. Polina Dombure to Speak at TOPRA Webinar "Navigating Regulatory Changes in Moldova and Ukraine"
October 16, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, примет участие в CPHI Milan 8-10 октября 2024
September 25, 2024
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
September 25, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
September 13, 2024
Dr. Polina Dombure to Speak at TOPRA Webinar on “Overcoming Regulatory Challenges in Azerbaijan and Georgia”
September 13, 2024